Fig. 1 · Structure

Documents & Downloads

BLZ945

Cat. No. A15540 CAS 953769-46-5

CSF1R inhibitor

BLZ945 is a potent and selective CSF-1R kinase inhibitor. It attenuates the turnover rate of TAMs while increasing the number of CD8+ T cells that infiltrate cervical and breast carcinomas.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
CSF-1R 1 nM

Cellular Effect

Cell Line Activity Value Description Reference
Panc02 IC50 18 μM Antitumour activity against mouse Panc02 cells implanted in po dosed C57BL/6 mouse assessed as reduction in EMR1 F4/80 mRNA expression after 5 days [PMID: 32787110]
Panc02 IC50 56 μM Antitumour activity against mouse Panc02 cells implanted in po dosed C57BL/6 mouse assessed as reduction in CD4 mRNA expression after 5 days [PMID: 32787110]

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 953769-46-5
Applications CSF1R inhibitor
Formula C20H22N4O3S
Molecular Weight 398.4
SMILES
CNC(=O)C1=NC=CC(=C1)OC2=CC3=C(C=C2)N=C(S3)NC4CCCCC4O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 77 mg/mL (193.23 mM)
Water Insoluble
Ethanol Warmed: 3 mg/mL

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

In Vivo Preparation

Concentration
2.3 mg/mL
Vehicle
4% DMSO+30% PEG 300+ddH2O

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...